NCIt definition : A synthetic derivative of androstane with adrenocortical suppressive properties. Trilostane
reversibly inhibits 3 beta-hydroxysteroid dehydrogenase delta 5-4 isomerase in the
adrenal cortex, resulting in the decreased synthesis of mineralocorticoids and glucocorticoids
and the decreased conversion of pregnenolone to progesterone. (NCI04);
NCIt note : This drug has been removed from the US market in 1994.;
UNII : L0FPV48Q5R;
InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N;
CAS number : 13647-35-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 13647-35-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;